Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Change in Acquisitions & Divestments (2022 - 2025)

Historic Change in Acquisitions & Divestments for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to $35.9 million.

  • Century Therapeutics' Change in Acquisitions & Divestments fell 3040.99% to $35.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $169.9 million, marking a year-over-year increase of 760.25%. This contributed to the annual value of $176.8 million for FY2024, which is 3772.78% down from last year.
  • Per Century Therapeutics' latest filing, its Change in Acquisitions & Divestments stood at $35.9 million for Q3 2025, which was down 3040.99% from $42.5 million recorded in Q2 2025.
  • In the past 5 years, Century Therapeutics' Change in Acquisitions & Divestments ranged from a high of $110.5 million in Q2 2023 and a low of $29.3 million during Q4 2023
  • Moreover, its 4-year median value for Change in Acquisitions & Divestments was $51.6 million (2024), whereas its average is $56.9 million.
  • As far as peak fluctuations go, Century Therapeutics' Change in Acquisitions & Divestments surged by 9317.43% in 2023, and later plummeted by 7296.63% in 2024.
  • Quarter analysis of 4 years shows Century Therapeutics' Change in Acquisitions & Divestments stood at $52.3 million in 2022, then plummeted by 44.06% to $29.3 million in 2023, then skyrocketed by 64.59% to $48.2 million in 2024, then fell by 25.52% to $35.9 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $35.9 million for Q3 2025, versus $42.5 million for Q2 2025 and $43.3 million for Q1 2025.